BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 3321494)

  • 21. [Use of sermion, Cavinton and trental in patients with cerebrovascular disorders].
    Lebedeva NV; Khrapova EV
    Sov Med; 1990; (1):60-3. PubMed ID: 2190329
    [No Abstract]   [Full Text] [Related]  

  • 22. [Treatment of chronic arterial circulatory disorders. Double blind trial with Trental 400 (author's transl)].
    Kellner H
    MMW Munch Med Wochenschr; 1976 Oct; 118(43):1399-1402. PubMed ID: 825745
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Intravenous pentoxifylline in Fontaine stage II and III peripheral arterial diseases].
    Giansante C; Di Chiara A; Fiotti N; Mauri F; Sorrentino A; Spanghero M; Tomasin L; Calabrese S
    Clin Ter; 1990 Sep; 134(5):301-5. PubMed ID: 2149312
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Assessment of the therapeutic effect of Trental 400. Double-blind study in geriatric patients with circulatory disorders].
    Feine-Haake G
    Fortschr Med; 1977 Jan; 95(1):48-51. PubMed ID: 401759
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Effects of pentoxifylline on blood viscosity and peripheral hemodynamics in patients with peripheral occlusive arteriopathies].
    Guerrini M; Pecchi S; Rossi C; Cappelli R; Pieragalli D; Acciavatti A
    Ric Clin Lab; 1981; 11 Suppl 1():265-79. PubMed ID: 7188114
    [No Abstract]   [Full Text] [Related]  

  • 26. Placebo controlled double-blind study of pentoxifylline in sickle cell disease patients.
    Manrique RV
    J Med; 1987; 18(5-6):277-91. PubMed ID: 3333162
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Treatment of peripheral arterial occlusive disorders with rheologically active measures].
    Turowski A; Schmidt HH; Sternitzky R
    Z Arztl Fortbild (Jena); 1987; 81(17):883-8. PubMed ID: 3439205
    [No Abstract]   [Full Text] [Related]  

  • 28. Drug therapy for peripheral arterial disease.
    Naide D
    Am Fam Physician; 1986 Sep; 34(3):215-7. PubMed ID: 3751848
    [No Abstract]   [Full Text] [Related]  

  • 29. Clinical results of pentoxifylline use in a community peripheral vascular surgical practice.
    Smith MA; Fish RC
    Monogr Atheroscler; 1990; 15():27-9. PubMed ID: 2296248
    [No Abstract]   [Full Text] [Related]  

  • 30. The treatment of chronic cerebrovascular insufficiency. A double-blind study with pentoxifylline ('Trental' 400).
    Harwart D
    Curr Med Res Opin; 1979; 6(2):73-84. PubMed ID: 380914
    [No Abstract]   [Full Text] [Related]  

  • 31. [Blood rheology in chronic arterial occlusive disease as influenced by vasodilators (author's transl)].
    Störmer B; Kleinschmidt F; Loose D; Kremer K
    Dtsch Med Wochenschr; 1978 Apr; 103(16):694-8. PubMed ID: 639718
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Haemorrheological improvement by pentoxifylline in patients with peripheral arterial occlusive disease.
    Perego MA; Sergio G; Artale F; Giunti P; Danese C
    Curr Med Res Opin; 1986; 10(2):135-8. PubMed ID: 3709212
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Design and method of clinical trials of drugs used in the therapy of stable peripheral arterial occlusive disease].
    Wink K
    Arzneimittelforschung; 2006; 56(1):52-7. PubMed ID: 16478006
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Therapeutic efficacy of pentoxifylline in peripheral artery diseases: its clinical value].
    Benignetti G; Fabbri F; Benvenuti C
    Clin Ter; 1983 Feb; 104(4):297-304. PubMed ID: 6861465
    [No Abstract]   [Full Text] [Related]  

  • 35. Pentoxifylline treatment in patients with occlusive peripheral arterial disease. Circulatory changes and effects on prostaglandin synthesis.
    Poggesi L; Scarti L; Boddi M; Masotti G; Serneri GG
    Angiology; 1985 Sep; 36(9):628-37. PubMed ID: 3901827
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Treatment of chronic arterial occlusive disease. Clinical study with a new galenic preparation of Pentoxifyllin (Trental 400) (author's transl)].
    Angelkort B; Doppelfeld E
    Med Klin; 1978 May; 73(21):791-7. PubMed ID: 651768
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Treatment of duodenal ulcer with trental].
    Vorob'ev LP; Ponomarev IuT; Samsonov AA; Agibalov IuV
    Sov Med; 1986; (2):99-102. PubMed ID: 3518079
    [No Abstract]   [Full Text] [Related]  

  • 38. [Therapy of arterial vascular occlusions of retinal and optic nerve (author's transl)].
    Küchle HJ; Richard G
    Ophthalmologica; 1979; 179(5):291-6. PubMed ID: 545196
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Ifenprodil tartrate in the treatment of occlusive arteriopathies of the lower limbs. Results of a prospective double-blind controlled multicenter trial].
    Natali J; Kieny R; Le Bas P; Benhamou M; Molkhou JM
    Ann Cardiol Angeiol (Paris); 1989 Jun; 38(6):339-42. PubMed ID: 2667444
    [No Abstract]   [Full Text] [Related]  

  • 40. Clinical application of prostaglandin E1 in cases of occlusive arterial disease.
    Mishima Y
    Adv Prostaglandin Thromboxane Leukot Res; 1985; 15():547-8. PubMed ID: 2936166
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.